David MacNaughtan
Private Equity Investor bei Canada Pension Plan Investment Board Private Investments
Profil
David MacNaughtan is currently a Senior Principal at Canada Pension Plan Investment Board Private Investments, a Partner at Sagard Holdings ULC, and the Partner & Head of Sagard Royalty Partners at Sagard Healthcare Royalties.
He previously worked as a Director at Isotechnika Pharma, Inc., a Director at Jaguar Health, Inc., and as the Executive VP & Co-Head-Royalty Monetization Fund at DRI Capital, Inc. He also served as the Vice President-Business Development at Paladin Labs, Inc. and as an Investment Manager at Royal Bank Capital Corp.
Mr. MacNaughtan holds an MBA from Rotman School of Management and both undergraduate and graduate degrees from Queen's University.
Aktive Positionen von David MacNaughtan
| Unternehmen | Position | Beginn |
|---|---|---|
Canada Pension Plan Investment Board Private Investments
 Canada Pension Plan Investment Board Private Investments Investment ManagersFinance Canada Pension Plan Investment Board Private Investments is a private equity firm, a subsidiary of Canada Pension Plan Investment Board, founded in 1966. The firm is headquartered in Toronto, Canada. | Private Equity Investor | 11.01.2011 |
Sagard Holdings ULC
 Sagard Holdings ULC Investment ManagersFinance Part of Power Corp. of Canada, Sagard Holdings ULC is a Canadian company that provides alternative asset management services. The company is based in Montréal, Canada. Founded in 2000. | Corporate Officer/Principal | 01.12.2018 |
Sagard Healthcare Royalties
 Sagard Healthcare Royalties Investment ManagersFinance Sagard Healthcare Royalties (Sagard Healthcare) is a venture capital subsidiary of Sagard Holdings ULC founded in 1900. The firm is headquartered in Toronto, Canada. | Private Equity Investor | 01.01.2019 |
Ehemalige bekannte Positionen von David MacNaughtan
| Unternehmen | Position | Ende |
|---|---|---|
| JAGUAR HEALTH, INC. | Direktor/Vorstandsmitglied | 21.02.2020 |
| PALADIN LABS INC. | Corporate Officer/Principal | 01.09.2002 |
| Royal Bank Capital Corp. | Corporate Officer/Principal | 01.08.1999 |
DRI Capital, Inc.
 DRI Capital, Inc. Investment ManagersFinance DRI Capital, Inc. (DRI Capital) is a private equity firm, a subsidiary of Persis Holdings Ltd founded in 1992. The firm is headquartered in Toronto, Canada. | Corporate Officer/Principal | - |
Isotechnika Pharma, Inc.
 Isotechnika Pharma, Inc. Pharmaceuticals: MajorHealth Technology Isotechnika Pharma, Inc. is a biopharmaceutical company, which focuses on discovery and development of immunomodulating therapeutics. Its products include voclosporin and non-immunosuppressive cyclosporine analogue molecules. The company was founded by Robert T. Foster founded on June 16, 1993 and is headquartered in Edmonton, Canada. | Direktor/Vorstandsmitglied | - |
Ausbildung von David MacNaughtan
| Queen's University | Graduate Degree |
| Rotman School of Management | Masters Business Admin |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| JAGUAR HEALTH, INC. | Health Technology |
| Private Unternehmen | 7 |
|---|---|
Isotechnika Pharma, Inc.
Isotechnika Pharma, Inc. Pharmaceuticals: MajorHealth Technology Isotechnika Pharma, Inc. is a biopharmaceutical company, which focuses on discovery and development of immunomodulating therapeutics. Its products include voclosporin and non-immunosuppressive cyclosporine analogue molecules. The company was founded by Robert T. Foster founded on June 16, 1993 and is headquartered in Edmonton, Canada. | Health Technology |
DRI Capital, Inc.
DRI Capital, Inc. Investment ManagersFinance DRI Capital, Inc. (DRI Capital) is a private equity firm, a subsidiary of Persis Holdings Ltd founded in 1992. The firm is headquartered in Toronto, Canada. | Finance |
Paladin Labs, Inc.
 Paladin Labs, Inc. Pharmaceuticals: MajorHealth Technology Paladin Labs Inc. operates as pharmaceutical company. It engages in developing, acquiring, in-licensing, marketing, and distributing innovative pharmaceutical products in Canada and internationally. The firm's products include Abstral, GlucaGen, Metadol, Plan B, Pennsaid, Seasonale, Testim, Twinject, Dexedrin, Tridural, and Trelstar. The company was founded by Jonathan Ross Goodman and Mark Beaudet on February 25, 1983 and is headquartered in Montreal, Canada. | Health Technology |
| Royal Bank Capital Corp. | |
Canada Pension Plan Investment Board Private Investments
Canada Pension Plan Investment Board Private Investments Investment ManagersFinance Canada Pension Plan Investment Board Private Investments is a private equity firm, a subsidiary of Canada Pension Plan Investment Board, founded in 1966. The firm is headquartered in Toronto, Canada. | Finance |
Sagard Holdings ULC
Sagard Holdings ULC Investment ManagersFinance Part of Power Corp. of Canada, Sagard Holdings ULC is a Canadian company that provides alternative asset management services. The company is based in Montréal, Canada. Founded in 2000. | Finance |
Sagard Healthcare Royalties
Sagard Healthcare Royalties Investment ManagersFinance Sagard Healthcare Royalties (Sagard Healthcare) is a venture capital subsidiary of Sagard Holdings ULC founded in 1900. The firm is headquartered in Toronto, Canada. | Finance |
